Name: Latest research reports of Ajanta Pharma Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Ajanta Pharma Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Turnaround Potential

2950.0000 -80.60 (-2.66%)

NSE Mar 16, 2026 14:41 PM

New 52W High in past week

Volume: 116.0K

Ajanta Pharma Ltd.

29 Jul 2025

2950.00

-2.66%

Ajanta Pharma (HOLD): Double-digit growth to continue; EBITDA margin constant

Hold: Ajanta Pharma Ltd.

Target

BOB Capital Markets Ltd.

Earnings were in line with our estimates with sales /EBITDA/PAT reported 1%/-2.7%/3% above estimates

Number of FII/FPI investors decreased from 343 to 316 in Dec 2025 qtr